Response to targeted radionuclide therapy with [
131I-MIBG therapy
PRRT (peptide receptor radionuclide therapy)
paraganglioma
pheochromocytoma
theragnostic agents
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
05
2022
accepted:
30
09
2022
entrez:
7
11
2022
pubmed:
8
11
2022
medline:
9
11
2022
Statut:
epublish
Résumé
Targeted radionuclide therapy (TRT) with [ This review was developed according to the PRISMA Statement with 27 final studies (608 patients). Patient characteristics, treatment procedure, and follow-up criteria were evaluated. In addition, a Bayesian linear regression model weighted according to its sample size and an alternative model, which also included an interaction between the treatment and the proportion of PHEOs, were carried out, adjusted by a Student's In linear regression models, [ Methodology, procedure, and PFS from the different studies are quite heterogeneous. PRRT-Lu showed better results globally and specifically in PHEOs. This fact opens the window to prospective trials comparing or sequencing [
Identifiants
pubmed: 36339441
doi: 10.3389/fendo.2022.957172
pmc: PMC9630737
doi:
Substances chimiques
3-Iodobenzylguanidine
35MRW7B4AD
Iodine-131
0
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
1HTE449DGZ
Radiopharmaceuticals
0
Iodine Radioisotopes
0
Types de publication
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
957172Informations de copyright
Copyright © 2022 Prado-Wohlwend, del Olmo-García, Bello-Arques and Merino-Torres.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Q J Nucl Med Mol Imaging. 2010 Feb;54(1):100-13
pubmed: 20168292
Eur J Nucl Med Mol Imaging. 2008 Apr;35(4):725-33
pubmed: 18071700
Clin Cancer Res. 2021 Jun 1;27(11):2989-2995
pubmed: 33685867
Clin Oncol (R Coll Radiol). 2003 Jun;15(4):193-8
pubmed: 12846498
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3278-3287
pubmed: 28605448
QJM. 2015 May;108(5):361-8
pubmed: 25267727
Med Oncol. 2016 May;33(5):47
pubmed: 27059363
Cancers (Basel). 2019 Oct 08;11(10):
pubmed: 31597347
Endocr Rev. 2017 Dec 1;38(6):489-515
pubmed: 28938417
Front Endocrinol (Lausanne). 2022 Feb 07;13:778322
pubmed: 35197929
Nucl Med Commun. 2011 Dec;32(12):1201-10
pubmed: 21968432
Clin Nucl Med. 2017 Jun;42(6):436-443
pubmed: 28263217
Cancers (Basel). 2019 May 16;11(5):
pubmed: 31100940
Am J Clin Oncol. 2010 Feb;33(1):79-82
pubmed: 19704370
Cancer. 2003 Jul 15;98(2):239-48
pubmed: 12872341
J Surg Oncol. 2017 Mar;115(4):425-434
pubmed: 28166370
Surgery. 2003 Dec;134(6):956-62; discussion 962-3
pubmed: 14668728
Ann N Y Acad Sci. 2006 Aug;1073:465-90
pubmed: 17102115
Ann Nucl Med. 2013 Nov;27(9):839-46
pubmed: 23864328
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2112-2137
pubmed: 31254038
Mol Imaging Biol. 2015 Jun;17(3):313-8
pubmed: 25319765
Histopathology. 2018 Jan;72(1):97-105
pubmed: 29239044
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):970-988
pubmed: 29497803
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31614368
Semin Nucl Med. 2020 Sep;50(5):447-464
pubmed: 32768008
Nucl Med Commun. 2018 Aug;39(8):789-796
pubmed: 29912750
J Nucl Med. 2021 Sep 1;62(9):1274-1277
pubmed: 33517327
Horm Metab Res. 2012 May;44(5):405-10
pubmed: 22566196
Clin Oncol (R Coll Radiol). 2001;13(5):361-6
pubmed: 11716230
J Nucl Med. 2019 May;60(5):623-630
pubmed: 30291194
J Clin Oncol. 2009 Sep 1;27(25):4162-8
pubmed: 19636009
N Engl J Med. 2019 Aug 8;381(6):552-565
pubmed: 31390501
Clin Endocrinol (Oxf). 2001 Jul;55(1):47-60
pubmed: 11453952
Endocr J. 2014;61(12):1171-80
pubmed: 25214026
J Endocrinol Invest. 2021 Jan;44(1):15-25
pubmed: 32602077
J Nucl Med. 2006 Oct;47(10):1599-606
pubmed: 17015894
Ann Oncol. 2020 Nov;31(11):1476-1490
pubmed: 32861807
Eur J Endocrinol. 2019 Jul;181(1):45-53
pubmed: 31067510
Nucl Med Mol Imaging. 2018 Jun;52(3):190-199
pubmed: 29942397
Endocr Connect. 2020 Oct;9(9):864-873
pubmed: 32784267
EJNMMI Res. 2019 Feb 6;9(1):13
pubmed: 30725219
Endocrine. 2011 Apr;39(2):160-6
pubmed: 21069578